Paper Details

  1. Home
  2. Paper Details

Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery.

Author:

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

The study successfully formulated solid lipid nanoparticles (SLNs) of finasteride decorated with chitosan, which enhanced drug retention in the skin and extended drug release. This approach could potentially reduce side effects, drug degradation, and the need for prolonged oral therapy in treating androgenetic alopecia and benign prostate hyperplasia.
Paper Details　
Original Abstract of the Article :
Finasteride is considered the drug of choice for androgenic alopecia and benign prostate hyperplasia. The aim of the study was to formulate nanodrug carriers of finasteride with enhanced retentive properties in the skin. The finasteride was formulated as solid lipid nanoparticles that were decorated...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/35971450

データ提供：米国国立医学図書館（NLM）

Finasteride for Hair Loss: A New Delivery System for Enhanced Efficacy

Androgenic alopecia, commonly known as male pattern baldness, is a prevalent condition affecting millions of people. This research explores the potential of chitosan-decorated solid lipid nanoparticles (SLNs) as a novel drug delivery system for finasteride, a medication used to treat androgenic alopecia. The authors aim to develop a formulation that enhances drug retention in the skin, potentially improving efficacy and reducing side effects compared to conventional oral finasteride therapy.

Chitosan-Decorated SLNs: A Targeted Approach to Hair Loss Treatment

The researchers successfully formulated chitosan-decorated SLNs containing finasteride, demonstrating enhanced drug retention in the skin and a sustained release profile. This targeted delivery system offers a potential advantage over conventional oral therapy, potentially improving efficacy by delivering the medication directly to the site of action while minimizing systemic exposure and reducing the risk of side effects.

Innovation in Drug Delivery: A Path to Improved Outcomes

This research highlights the ongoing innovation in drug delivery systems, with the development of nanocarriers like SLNs offering a new frontier for therapeutic delivery. The authors demonstrate the potential of chitosan decoration to enhance drug retention and optimize therapeutic outcomes, suggesting a promising avenue for developing more effective and well-tolerated treatments for androgenic alopecia.

Dr.Camel's Conclusion

Just as a camel carries essential supplies on its long journeys through the desert, this research explores the potential of nanocarriers to deliver finasteride directly to the site of action, maximizing therapeutic benefits while minimizing potential risks. The development of chitosan-decorated SLNs represents a promising advancement in drug delivery, offering a potentially more effective and well-tolerated approach to treating androgenic alopecia.

Date :
  1. Date Completed 2022-08-17
  2. Date Revised 2022-08-17
Further Info :

Pubmed ID

35971450

DOI: Digital Object Identifier

Related Literature

Article Analysis
・Side Effects of finasteride
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.